DDD Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against 3D Systems Corporation

Core Viewpoint - A class action has been filed against 3D Systems Corporation for allegedly misleading investors regarding its business prospects and financial performance [1][2]. Group 1: Allegations and Financial Performance - The complaint alleges that 3D Systems understated the impact of weakened customer spending and overstated its resilience in challenging industry conditions [2]. - The updated milestone criteria in the United Partnership are claimed to negatively impact the revenue of the Company's Regenerative Medicine Program [2]. - On March 26, 2025, 3D Systems announced disappointing financial results for Q4 and full-year 2024, leading to a stock price drop of $0.57 per share, or 20.96%, closing at $2.15 on March 27, 2025 [3]. - For Q1 2025, 3D Systems reported revenue of $94.5 million, down 8% year-over-year, missing consensus estimates of $99.5 million, and a net loss of $37 million, or $0.28 per share, more than doubling the $16 million loss from Q1 2024 [4]. - The adjusted loss per share was $0.21, deeper than the consensus estimate of a loss of $0.14, and adjusted EBITDA showed a loss of $23.9 million, worsening from a $20.1 million loss in Q1 2024 [4]. - The Company attributed its disappointing results to a decline in material sales, particularly due to inventory management issues in the dental segment of its Healthcare Solutions [4]. - 3D Systems withdrew its full-year 2025 outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty [4]. - Following the Q1 results announcement, the stock price fell $0.68 per share, or 26.6%, closing at $1.87 on May 13, 2025 [4].